SML3457

JX06

≥98% (HPLC)

• 동의어(들): 4,4′-(Dithiodicarbonothioyl)bis[morpholine], 4-Morpholinethiocarbonyl disulfide, Bis(4-morpholinethiocarbonyl) disulfide, Bis(oxydi-2,1-ethanediyl)-thiuram disulfide, Dimorpholinethiuram disulfide, JX 06, JX-06, NSC 402538
• 실험식(Hill 표기법): C₁₀H₁₆N₂O₂S₄
• CAS Number: 729-46-4
• Molecular Weight: 324.51
• MDL number: MFCD00072237
• UNSPSC 코드: 12352200
• NACRES: NA.77

속성

• Quality Level: 100
• 분석: ≥98% (HPLC)
• 양식: powder
• 색상: white to beige
• solubility: DMSO: 2 mg/mL, clear
• 저장 온도: -10 to -25°C
• SMILES string: S(SC(=S)N2CCOCC2)C(=S)N1CCOCC1
• InChI: 1S/C10H16N2O2S4/c15-9(11-1-5-13-6-2-11)17-18-10(16)12-3-7-14-8-4-12/h1-8H2
• InChI key: KKVYOWPPMNSLCP-UHFFFAOYSA-N

설명

생화학적/생리학적 작용

JX06 is a potent, PDK1-selective, covalent pyruvate dehydrogenase (PDH) kinase (PDHK, PDK) inhibitor (PDK1/2/3 IC50 = 49/101/313 nM; PDK4 IC50 >10 µM, IC50 >10 µM against >300 other kinases). JX06 inhibits cellular PDK substrate PDHA1 Ser293/232 phosphorylation, resulting in reduced aerobic glycolysis and cancer proliferation in cultures (1-10 µM) and in mice in vivo (40-80 mg/kg via daily i.p. injection; A549 & HT-29 xenografts). JX06 is shown to target PDK1 Cys240 for covalent modification.

Potent, PDK1-selective, covalent pyruvate dehydrogenase kinase (PDHK, PDK) inhibitor with anti-cancer efficacy in vitro and in vivo.

안전성 정보

• 픽토그램: GHS07
• 신호어: Warning
• 유해 및 위험 성명서: H315,H319
• 예방조치 성명서: P264 - P280 - P302 + P352 - P305 + P351 + P338 - P332 + P313 - P337 + P313
• Hazard Classifications: Eye Irrit. 2 - Skin Irrit. 2
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3
• Flash Point (°F): Not applicable
• Flash Point (°C): Not applicable